<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Medicine (Baltimore)</journal-id><journal-id journal-id-type="iso-abbrev">Medicine (Baltimore)</journal-id><journal-id journal-id-type="publisher-id">MD</journal-id><journal-title-group><journal-title>Medicine</journal-title></journal-title-group><issn pub-type="ppub">0025-7974</issn><issn pub-type="epub">1536-5964</issn><publisher><publisher-name>Lippincott Williams &#x00026; Wilkins</publisher-name><publisher-loc>Hagerstown, MD</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40388758</article-id><article-id pub-id-type="pmc">PMC12091603</article-id>
<article-id pub-id-type="publisher-id">MD-D-23-11027</article-id><article-id pub-id-type="art-access-id">00039</article-id><article-id pub-id-type="doi">10.1097/MD.0000000000042400</article-id><article-version vocab="JAV" vocab-identifier="http://www.niso.org/publications/rp/RP-8-2008.pdf" article-version-type="Version of Record">3</article-version><article-categories><subj-group subj-group-type="heading"><subject>4900</subject></subj-group><subj-group><subject>Research Article</subject><subject>Observational Study</subject></subj-group></article-categories><title-group><article-title>The effect of T cells on the lncRNA4.9-TGF-&#x003b2;1 axis in HCMV latently infected cells</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Yi</surname><given-names>Xiaolian</given-names></name><degrees>MD</degrees><email>yIXIAO@126.COM</email><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Lifang</given-names></name><degrees>MD</degrees><email>LIIUY@126.com</email><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Tao</surname><given-names>Ran</given-names></name><degrees>MD</degrees><email>taoran@126.com</email><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Wei</given-names></name><degrees>MD</degrees><email>lihua@126.com</email><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Huamei</given-names></name><degrees>MD</degrees><email>lihua@126.com</email><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>He</surname><given-names>Lin</given-names></name><degrees>MD</degrees><email>helin@126.com</email><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Yujie</given-names></name><degrees>MD</degrees><email>LIIUY@126.com</email><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-8935-0047</contrib-id><name><surname>Shang</surname><given-names>Shiqiang</given-names></name><degrees>MD</degrees><xref rid="aff1" ref-type="aff">a</xref><xref rid="c1" ref-type="corresp">*</xref></contrib><aff id="aff1"><label>a</label>Department of Laboratory Center, Children&#x02019;s Hospital Affiliated to Zhejiang University School of Medicine, Hangzhou, China.</aff></contrib-group><author-notes><corresp id="c1"><label>*</label>Correspondence: Shiqiang Shang, Department of Laboratory Center, Children&#x02019;s Hospital Affiliated to Zhejiang University School of Medicine, Hangzhou 310051, China (e-mail: <email xlink:href="shangsq0803@126.com">shangsq0803@126.com</email>).</corresp></author-notes><pub-date pub-type="collection"><day>16</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="epub"><day>16</day><month>5</month><year>2025</year></pub-date><volume>104</volume><issue>20</issue><elocation-id>e42400</elocation-id><history><date date-type="received"><day>6</day><month>12</month><year>2023</year></date><date date-type="received"><day>28</day><month>3</month><year>2025</year></date><date date-type="accepted"><day>22</day><month>4</month><year>2025</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2025 the Author(s). Published by Wolters Kluwer Health, Inc.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article distributed under the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License 4.0 (CCBY)</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:href="medi-104-e42400.pdf"/><abstract><p>Human cytomegalovirus (HCMV), a prevalent double-stranded DNA virus, exhibits a high infectioraten, yet the mechanisms underlying latent infection and activation remain unclear. Viral cyclic reactivation in healthy HCMV and latent infection is usually well controlled by the T-cell response. Long noncoding RNA (lncRNA) is known to play vital roles in physiological and pathological processes. This study investigates the impact of T cells on the expression of lncRNA4.9, transforming growth factor-&#x003b2; (TGF-&#x003b2;), and multiple cytokines during HCMV latent infection. We established an HCMV latent infection model, coculturing human acute monocytic leukemia cell line (THP-1) cells with T cells subjected to different treatments: NC1 (THP-1 cells cocultured with untreated T cells), NC2 (HCMV latently infected group without T cells), phytohemagglutinin A (PHA) group (PHA-activated T cells added), FK506 group (FK506-suppressed T cells added), and T-cell group (untreated T cells added). Cytokines were assessed in cell culture supernatants collected at 24, 48, and 72 hours. Reverse transcription-quantitative polymerase chain reaction examined changes in RNA and HCMV DNA copy numbers after 3 and 5 days. In the HCMV latent infection model, PHA group, T-cell group, and FK506 group exhibited significantly increased interleukin (IL)-6, IL-10, and tumor necrosis factor-alpha secretion. Expressions of lncRNA4.9 and TGF-&#x003b2;1 significantly increased in T-cell group after 3 and 5 days. Expressions of lncRNA4.9 and TGF-&#x003b2;1 significantly decreased in the PHA group after 5 days. DNA copy numbers of HCMV decreased in T cell and PHA groups after 3 days, with no significant change after 5 days. This study reveals that PHA-activated T cells downregulate the expression of lncRNA4.9 and TGF-&#x003b2;1 in HCMV, highlighting the effect of T cells on the lncRNA4.9-TGF-&#x003b2;1 axis during HCMV latent infection. Regardless of T-cell activation, the study also indicates that IL-6, IL-10, and tumor necrosis factor-alpha levels increase during HCMV latent infection.</p></abstract><kwd-group><kwd>cytokines</kwd><kwd>human cytomegalovirus</kwd><kwd>latent infection</kwd><kwd>lncRNA4.9</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>OPEN-ACCESS</meta-name><meta-value>TRUE</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro"><title>1. Introduction</title><p>Human cytomegalovirus (HCMV) is a ubiquitous &#x003b2;-herpesvirus with a population prevalence of 60% to 90%.<sup>[<xref rid="R1" ref-type="bibr">1</xref>]</sup> The expression of immediate-early protein 2 (IE2), encoded by <italic toggle="yes">UL122</italic>, increases during HCMV proliferative infection but significantly decreases after 2 to 3 days and remains low or absent during latent infection.<sup>[<xref rid="R2" ref-type="bibr">2</xref>,<xref rid="R3" ref-type="bibr">3</xref>]</sup> When IE2 expression is low or absent, but the <italic toggle="yes">UL138</italic> gene is expressed, it indicates that HCMV is in a latent state. Notably, UL138 serves as a marker protein for HCMV latent infection.<sup>[<xref rid="R4" ref-type="bibr">4</xref>&#x02013;<xref rid="R6" ref-type="bibr">6</xref>]</sup> Long-stranded noncoding RNA (lncRNA) is a class of noncoding RNAs which is longer than 200 nucleotides (nt) and do not encode proteins.<sup>[<xref rid="R7" ref-type="bibr">7</xref>]</sup> Currently, the known mechanisms of action of lncRNAs are 2-fold: regulation at the transcriptional level and regulation at the posttranscriptional level. During the proliferative infection process, HCMV primarily expresses 4 lncRNAs &#x02013; lncRNA1.2, lncRNA2.7, lncRNA4.9, and lncRNA5.0.<sup>[<xref rid="R2" ref-type="bibr">2</xref>,<xref rid="R8" ref-type="bibr">8</xref>]</sup> lncRNA4.9 has been identified from the HCMV expression profile, with a transcript length of 4922&#x02009;bp.<sup>[<xref rid="R9" ref-type="bibr">9</xref>]</sup> It has been suggested that lncRNA4.9 plays a crucial role in viral DNA replication and proliferation.<sup>[<xref rid="R10" ref-type="bibr">10</xref>]</sup> It has been found that the inhibition of lncRNA4.9 during late latent infection increases IE2 expression and HCMV copy numbers, suggesting activation of HCMV proliferative infection.<sup>[<xref rid="R11" ref-type="bibr">11</xref>&#x02013;<xref rid="R13" ref-type="bibr">13</xref>]</sup> Our research team&#x02019;s experiments have shown that the inhibition of lncRNA4.9 and NGFI-A binding protein 2 significantly upregulates the expression of early growth response gene 1 (<italic toggle="yes">EGR1</italic>).<sup>[<xref rid="R13" ref-type="bibr">13</xref>]</sup> Previous studies have shown that EGR1 promotes the expression of transforming growth factor-&#x003b2; (TGF-&#x003b2;) after binding with and being activated by IE2.<sup>[<xref rid="R14" ref-type="bibr">14</xref>,<xref rid="R15" ref-type="bibr">15</xref>]</sup> There is a correlation between the expression of lncRNA4.9 and TGF-&#x003b2; in HCMV infection. TGF-&#x003b2; is an immunosuppressive factor that inhibits T-cell activation as well as the expression and secretion of several of their cytokines, including interleukin (IL)-2, IL-10, tumor necrosis factor-alpha (TNF-&#x003b1;), and interferon-&#x003b3; (IFN-&#x003b3;).<sup>[<xref rid="R16" ref-type="bibr">16</xref>]</sup> This study investigates the impact of T-cell activation on the expression levels of HCMV lncRNA4.9, TGF-&#x003b2;, and various cytokines (IL-2, IL-6, IL-10, TNF-&#x003b1;, IFN-&#x003b3;, etc) during HCMV latent infection. The findings will provide experimental evidence to support clinical strategies for the treatment and prevention of HCMV.</p></sec><sec sec-type="methods"><title>2. Materials and methods</title><sec><title>2.1. Cell and virus culture</title><p>Human acute monocytic leukemia cell line (THP-1) cells (3101HUMTCHu57, mycoplasma-free, 80% confluency) and human embryo fibroblast (HEF) cells (human embryonic fibroblasts, 3101HUMGNHu33, mycoplasma-free, 80% confluency) were obtained from the Cell Bank of the Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences. THP-1 cells were cultured in RPMI-1640 (Hyclone, Logan) with 10% fetal bovine serum (FBS; Gibco, Gaithersburg) and 0.05&#x02009;mM &#x003b2;-mercaptoethanol (Sigma, St. Louis). HEF cells were cultured in a modified minimal essential medium (Dulbecco<sup>,</sup>s Modified Eagle Medium [DMEM]) (Hyclone) containing 10% FBS. All cells were maintained in a saturated humidity incubator at 37&#x000b0;C with 5% CO<sub>2</sub>.</p><p>The HCMV Towne strain was kindly provided by Professor Jun Fan from the First Affiliated Hospital of Zhejiang University School of Medicine. When HEF cells (5th&#x02013;6th passage) reached 70% confluency, serum-free DMEM medium was added to the culture flask. The HCMV Towne strain was then inoculated at a multiplicity of infection (MOI) of 2, and the cells were incubated at 37&#x000b0;C in a humidified atmosphere containing 5% CO<sub>2</sub> for 2 hours. Following the incubation period, the medium was replaced with DMEM containing 2% FBS, and the culture was maintained for an additional 3 to 4 days. Subsequently, HEF cells were harvested, and the supernatant containing HCMV was collected and stored in liquid nitrogen at &#x02212;80&#x000b0;C.<sup>[<xref rid="R10" ref-type="bibr">10</xref>]</sup></p></sec><sec><title>2.2. Isolation of single-nucleated cells from peripheral blood and T-cell purification</title><p>T cells were isolated from fresh human peripheral blood obtained from healthy donors without HCMV, human immunodeficiency virus, or other common viral infections (hepatitis A, hepatitis B, hepatitis C, hepatitis E, Epstein&#x02013;Barr virus). The isolation and purification were performed using a human lymphocyte isolation solution (Tianjin Hao Yang Hua Ke Biotechnology Co., Ltd). and a T-cell negative selection magnetic bead sorting kit (No. 11344D; Invitrogen, Carlsbad). The purity of T cells (including CD4<sup>+</sup> T cells and CD8<sup>+</sup> T cells) was confirmed by flow cytometry (Leukemia Laboratory), Children&#x02019;s Hospital, Zhejiang University School of Medicine, BD FACS Calibur), with a purification rate exceeding 85%.</p></sec><sec><title>2.3. T-cell activation and inhibition</title><p>T cells were either activated using phytohemagglutinin (PHA, 5 &#x000b5;g/mL; Roche, Beijing, China) or inhibited by tacrolimus (FK506, 10&#x02009;ng/ml; Solarbio, Beijing, China) for 12 hours before coculturing with THP-1 cells.<sup>[<xref rid="R14" ref-type="bibr">14</xref>,<xref rid="R15" ref-type="bibr">15</xref>]</sup> T cells(at 2&#x02005;&#x000d7;&#x02005;10<sup>5</sup> cells/well) was added to each group except NC2 group.</p></sec><sec><title>2.4. Establishment of latent infection model and coculture model</title><sec><title>2.4.1. Establishment of latent infection model</title><p>One day before transfection, THP-1 cells (5th&#x02013;6th generation cells, cell density 50%&#x02013;60%) were planted at 2&#x02005;&#x000d7;&#x02005;10<sup>5</sup> cells/well into 2 very low-adherence 6-well plates (Corning, Corning) in a volume of 1&#x02009;mL culturing medium. On the day of transfection, counted the cells again, 4&#x02005;&#x000d7;&#x02005;10<sup>5</sup> cells per well, added serum-free 1640-diluted lentivirus (MOI&#x02005;=&#x02005;30) according to the amount of discarded culture medium, and added HCMV Towne at MOI&#x02005;=&#x02005;5 after 6 hours of culture, and cultured in different conditions to establish a latent infection model.<sup>[<xref rid="R10" ref-type="bibr">10</xref>]</sup> The experiment involved 5 groups (10 well per group): NC1 (THP-1 cells cocultured with untreated T cells), NC2 (HCMV latently infected group without T cells), PHA group (HCMV latently infected group with PHA-activated T cells), FK506 group (HCMV latently infected group with FK506-suppressed T cells), and T-cell group (HCMV latently infected group with untreated T cells). Various parameters were measured at different time points.<sup>[<xref rid="R17" ref-type="bibr">17</xref>&#x02013;<xref rid="R19" ref-type="bibr">19</xref>]</sup> Added T cells (at 2&#x02005;&#x000d7;&#x02005;10<sup>5</sup> cells/well) to each group except the NC2 group on the 6th day of latent infection, then cultured them in RPMI-1640 supplemented with 10% FBS. The experiment was repeated 3 times.</p></sec></sec><sec><title>2.5. Validation of HCMV latent phase infection</title><p>To validate latent HCMV infection in THP-1 cells, we employed a multiparametric approach encompassing cellular morphological analysis, quantitative assessment of intracellular viral genome copies, and evaluation of proliferation-associated gene expression profiles. Viral infection kinetics were monitored at 2 strategically selected time points (5 and 7 days postinfection) to capture critical transition phases. For molecular characterization, we performed simultaneous RNA isolation and protein extraction from HCMV-infected THP-1 cells. The infection status was determined through complementary polymerase chain reaction (PCR) analysis and Western blot detection of 2 key viral proteins: immediate-early protein IE2 (a lytic phase marker) and UL138 (a latent infection indicator), with GAPDH serving as the loading control. The establishment of viral latency was confirmed by the distinctive molecular signature: the absence of IE2 protein expression at 5 days postinfection coupled with sustained UL138 protein detection, which is pathognomonic for the transition to HCMV latent phase.<sup>[<xref rid="R10" ref-type="bibr">10</xref>]</sup></p></sec><sec><title>2.6. Detection of HCMV DNA by fluorescence quantitative PCR</title><p>Fluorescence quantitative PCR (qPCR) was used to detect HCMV DNA in supernatant samples. Sample preparation, reaction mix preparation, and PCR amplification procedures were conducted following standard protocols,<sup>[<xref rid="R14" ref-type="bibr">14</xref>]</sup> with the DNA copy number calculated based on a standard curve.</p></sec><sec><title>2.7. Reverse transcription qPCR</title><p>Four experimental groups (PHA group, T-cell group, FK506 group, and normal control group) were established to investigate the expression of HCMV lncRNA4.9, UL138, RNA extraction, reverse transcription, and PCR amplification were performed using established protocols, and relative expression was analyzed by the 2-&#x00394;&#x00394;CT method with GAPDH as the internal control.<sup>[<xref rid="R10" ref-type="bibr">10</xref>]</sup> The primer sequences are presented in Table <xref rid="T1" ref-type="table">1</xref>.</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Primer sequences.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Gene names</th><th align="center" rowspan="1" colspan="1">Sequences</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">GAPDH</td><td align="center" rowspan="1" colspan="1">Forward: 5&#x02032;- GAAGGTGAAGGGTCGGAGTC-3&#x02032;</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">Reverse: 5&#x02032;-GAAGATGGTGATGGGATTC-3&#x02032;</td></tr><tr><td align="left" rowspan="1" colspan="1">lncRNA4.9</td><td align="center" rowspan="1" colspan="1">Forward: 5&#x02032;-CCGCCATGACCACCAAAAAG-3&#x02032;</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">Reverse: 5&#x02032;-GCCGCTCTCTTACGTATCCC-3&#x02032;</td></tr><tr><td align="left" rowspan="1" colspan="1">TGF-&#x003b2;1</td><td align="center" rowspan="1" colspan="1">Forward: 5&#x02032;-CATACTGGGAATCGTGAAGG-3&#x02032;</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">Reverse: 5&#x02032;-TTGGACAACGAGAAGGTGC-3&#x02032;</td></tr><tr><td align="left" rowspan="1" colspan="1">UL138</td><td align="center" rowspan="1" colspan="1">Forward: 5&#x02032;-TATCGTCTGTCCGACTCCCG-3&#x02032;</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">Reverse: 5&#x02032;-TGGCACGACACCTTCAAACTGG-3&#x02032;</td></tr></tbody></table><table-wrap-foot><fn fn-type="other"><p>lncRNA = long noncoding RNA, TGF-&#x003b2;1 = transforming growth factor-&#x003b2;1.</p></fn></table-wrap-foot></table-wrap></sec><sec><title>2.8. Enzyme-linked immunosorbent assay</title><p>Some cell culture supernatant was collected from the 5 groups after 3 and 5 days to detect the protein expression of TGF-&#x003b2;1 by ELISA Kit for transforming-growth factor &#x003b2;1 (Serial. no. 336A99B577; Cloud-Clone Corp., Wuhan, China), the samples were detected with a SynergyH1 multifunction microplate detector (BioTek, Winooski).</p></sec><sec sec-type="methods"><title>2.9. Statistical methods</title><p>Statistical analyses were performed using SPSS 25.0 (IBM Corp., Armonk) and GraphPad Prism 8.0 (GraphPad Software, San Diego). The normality of data distribution was assessed using the Shapiro&#x02013;Wilk test. For group comparisons, a one-way analysis of variance was applied for normally distributed data, followed by the Tukey post hoc test for multiple comparisons. Nonnormally distributed data were analyzed using the Kruskal&#x02013;Wallis test, with the Dunn test for post hoc comparisons. All tests were 2-tailed, and statistical significance was set at <italic toggle="yes">P</italic>&#x02005;&#x0003c;&#x02005;.05.</p></sec></sec><sec sec-type="results"><title>3. Results</title><sec><title>3.1. Cytokine profiling in the latent infection model</title><p>Cytokine expression profiles (IL-2, IL-4, IL-6, and IL-10) were analyzed in the latent infection model using flow cytometry. Cell culture supernatants were collected at 24, 48, and 72 hours post-T-cell coculture. The experimental design comprised 4 distinct groups: normal control group 1 (NC1, THP-1 cells cocultured with untreated T cells), PHA-stimulated group, FK506-treated group, and T-cell-activated group. Normal control group 2 (NC2), consisting of THP-1 cells without T cells, served as a negative control for cytokine and IFN-&#x003b3; expression.</p><p>Comparative analysis revealed significant temporal increases in IL-2, IL-6, and IL-10 secretion in both PHA-stimulated and T cell-activated groups relative to NC1 at all time points (Figs. <xref rid="F1" ref-type="fig">1</xref>A, C, and D). In contrast, IL-4 expression remained stable across all groups, independent of T-cell activation status (Fig. <xref rid="F1" ref-type="fig">1</xref>B). These findings demonstrate that IL-6 and IL-10 production is specifically upregulated during latent HCMV infection.</p><fig position="float" id="F1"><label>Figure 1.</label><caption><p>Analysis of T-cell activation by measuring cytokines release. Secretion of (A) IL-2, (B) IL-4, (C) IL-6, (D) IL-10 was detected at 24, 48, and 72&#x02009;h after T cells added by flow cytometry. PHA. Phytoalexin-activated T-cell group. K506 group. tacrolimus (K506)-suppressed T cells group. NC1 group. normal control group 1. One-way ANOVA was applied for the 2-way comparison between different groups. ***<italic toggle="yes">P</italic>&#x02005;&#x0003c;&#x02005;.001, **<italic toggle="yes">P</italic>&#x02005;&#x0003c;&#x02005;.01, *<italic toggle="yes">P</italic>&#x02005;&#x0003c;&#x02005;.05. ANOVA = analysis of variance, IL = interleukin, PHA = phytohemagglutinin A.</p></caption><graphic xlink:href="medi-104-e42400-g001" position="float"/></fig></sec><sec><title>3.2. Proinflammatory cytokine dynamics in latent infection</title><p>The temporal expression patterns of TNF-&#x003b1; and IFN-&#x003b3; were quantitatively assessed throughout the coculture period. TNF-&#x003b1; secretion demonstrated a progressive increase across all experimental groups compared with NC1 controls (Fig. <xref rid="F2" ref-type="fig">2</xref>A). Notably, IFN-&#x003b3; expression was markedly elevated in both T cell-activated and PHA-stimulated groups relative to NC1 (Fig. <xref rid="F2" ref-type="fig">2</xref>B). These observations establish that TNF-&#x003b1; and IFN-&#x003b3; pathways are significantly upregulated during latent HCMV infection in the presence of activated T cells.</p><fig position="float" id="F2"><label>Figure 2.</label><caption><p>Analysis of T-cell activation by measuring cytokines release. Secretion of TNF-&#x003b1; (A) d IFN-&#x003b3; (B) was detected at 24, 48, and 72&#x02009;h after T cells added by flow cytometry. All those groups were compared with the T-cell group. PHA. Phytoalexin-activated T-cell group. K506 group. tacrolimus (K506)-suppressed T cells group. NC 1 group. normal control group 1. One-way ANOVA was applied for the 2-way comparison between different groups. ***<italic toggle="yes">P</italic>&#x02005;&#x0003c;&#x02005;.001, **<italic toggle="yes">P</italic>&#x02005;&#x0003c;&#x02005;.01, *<italic toggle="yes">P</italic>&#x02005;&#x0003c;&#x02005;.05. ANOVA = analysis of variance, IFN-&#x003b3; = interferon &#x003b3;, PHA = phytohemagglutinin A, TNF-&#x003b1; = tumor necrosis factor alpha.</p></caption><graphic xlink:href="medi-104-e42400-g002" position="float"/></fig></sec><sec><title>3.3. Molecular markers of latent infection</title><p>The expression profiles of lncRNA4.9, UL138, and TGF-&#x003b2;1 were evaluated in 4 experimental conditions: NC2 (HCMV-latently infected THP-1 cells without T cells), PHA-stimulated group, FK506-treated group, and T cell-activated group. NC1 (uninfected THP-1 cells with T cells) served as a negative control for HCMV-specific messenger RNA expression.</p><p>Quantitative analysis revealed that lncRNA4.9 and TGF-&#x003b2;1 expression levels were significantly elevated in both T cell-activated and FK506-treated groups compared with NC2 following 3 to 5 days of coculture (Fig. <xref rid="F3" ref-type="fig">3</xref>A&#x02013;C). The PHA group exhibited a transient increase at day 3, followed by subsequent downregulation. UL138 expression remained stable throughout the 5-day observation period (Fig. <xref rid="F3" ref-type="fig">3</xref>B). These data suggest that T-cell interaction modulates lncRNA4.9 and TGF-&#x003b2;1 expression during latent infection.</p><fig position="float" id="F3"><label>Figure 3.</label><caption><p>Analysis of RNA and HCMV DNA copy number in the host cells. After 5 day&#x02019;s treatment, the expression of lncRNA4.9 (A and C), TGF-&#x003b2;1 (B), and UL138 (C) was detected at 3 and 5 d after T cells added by RT-qPCR, the copies of HCMV were detected by qPCR. PHA. Phytoalexin-activated T-cell group. K506 group. tacrolimus (K506)-suppressed T cells group. NC 1 group. normal control group 1.One-way ANOVA was applied for the 2-way comparison between different groups. ***<italic toggle="yes">P</italic>&#x02005;&#x0003c;&#x02005;.001, **<italic toggle="yes">P</italic>&#x02005;&#x0003c;&#x02005;.01, *<italic toggle="yes">P</italic>&#x02005;&#x0003c;&#x02005;.05. ANOVA = analysis of variance, HCMV = human cytomegalovirus, lncRNA = long noncoding RNA, mRNA = messenger RNA, RT-qPCR = reverse transcription-quantitative polymerase chain reaction, TGF-&#x003b2;1 = transforming growth factor-&#x003b2;1.</p></caption><graphic xlink:href="medi-104-e42400-g003" position="float"/></fig></sec><sec><title>3.4. Quantitative analysis of HCMV replication</title><p>Viral replication dynamics were assessed through qPCR analysis of HCMV DNA copy number in THP-1 cells following 3 and 5 days coculture periods with differentially treated T cells. Both T cell-activated and PHA-treated groups demonstrated a significant reduction in HCMV DNA copy number at day 3 compared with NC controls (<italic toggle="yes">P</italic>&#x02005;&#x0003c;&#x02005;.05; Fig. <xref rid="F3" ref-type="fig">3</xref>D). However, this suppressive effect was not maintained at day 5, indicating transient viral suppression during early latent infection.</p></sec></sec><sec sec-type="discussion"><title>4. Discussion</title><p>HCMV infection elicits a robust cell-mediated immune response, characterized by sequential activation of natural killer cells followed by adaptive immune components, including high-affinity neutralizing antibodies, CD4<sup>+</sup>/CD8<sup>+</sup> T cells, and B cells.<sup>[<xref rid="R17" ref-type="bibr">17</xref>&#x02013;<xref rid="R19" ref-type="bibr">19</xref>]</sup> Despite this comprehensive immune activation, HCMV establishes lifelong persistence through sophisticated immune evasion strategies. The virus encodes cytokine homologs, such as UL146 (IL-8-like) and UL111a (viral IL-10), which play crucial roles in immune modulation.<sup>[<xref rid="R20" ref-type="bibr">20</xref>,<xref rid="R21" ref-type="bibr">21</xref>]</sup> Notably, the viral IL-10 homolog suppresses Th1 cytokine production (IFN-&#x003b3; and IL-2) and inhibits monocyte/macrophage-mediated inflammatory responses while downregulating major histocompatibility complex-II expression, thereby impairing antigen presentation to CD4<sup>+</sup> T cells.<sup>[<xref rid="R22" ref-type="bibr">22</xref>]</sup></p><p>Our experimental findings demonstrate significant upregulation of IL-6, IL-10, and TNF-&#x003b1; in the latent infection model, independent of T-cell activation status. This cytokine profile aligns with previous reports and suggests their potential utility as biomarkers for distinguishing between latent and active HCMV infection states. In immunocompetent individuals, T-cell responses typically maintain effective control over viral reactivation cycles during latent infection.<sup>[<xref rid="R23" ref-type="bibr">23</xref>,<xref rid="R24" ref-type="bibr">24</xref>]</sup> HCMV&#x02019;s ability to establish persistent infection across multiple tissues is facilitated by sustained transcriptional activity of specific viral genes, including UL138, LUNA, US28, UL111A, and UL144.<sup>[<xref rid="R25" ref-type="bibr">25</xref>]</sup></p><p>Building upon our previous findings that lncRNA4.9 regulates EGR1 and TGF-&#x003b2;1 expression to promote viral latency,<sup>[<xref rid="R11" ref-type="bibr">11</xref>]</sup> the current study reveals significant upregulation of both lncRNA4.9 and TGF-&#x003b2;1 in T cell and FK506-treated groups compared with NC2 controls. The FK506 group exhibited increased HCMV DNA levels, consistent with previous reports,<sup>[<xref rid="R23" ref-type="bibr">23</xref>,<xref rid="R24" ref-type="bibr">24</xref>]</sup> suggesting a temporal correlation between lncRNA4.9/TGF-&#x003b2;1 expression and viral latency establishment.</p><p>The immunosuppressive effects of TGF-&#x003b2; are well-documented, particularly its inhibition of T-cell activation and cytokine production (IL-2, IL-10, TNF-&#x003b1;, and IFN-&#x003b3;).<sup>[<xref rid="R16" ref-type="bibr">16</xref>]</sup> Our temporal analysis revealed distinct expression patterns: PHA treatment induced transient lncRNA4.9 and TGF-&#x003b2;1 upregulation at day 3, followed by progressive downregulation. This pattern correlated with reduced HCMV DNA levels in both T cell and PHA groups, suggesting that PHA-activated T cells effectively suppress viral latency-associated molecules. These findings highlight the potential of lncRNA4.9 and TGF-&#x003b2;1 as quantitative biomarkers for assessing T-cell activation status in HCMV-seropositive individuals.</p></sec><sec><title>5. Conclusion</title><p>This study provides compelling evidence that PHA-activated T cells modulate the lncRNA4.9-TGF-&#x003b2;1 axis during HCMV latent infection. We identified characteristic cytokine profiles (elevated IL-6, IL-10, and TNF-&#x003b1;) associated with viral latency, independent of T-cell activation status. The innovative incorporation of T cells in our experimental model provides novel insights into their regulatory effects on viral latency-associated molecules. While our in vitro findings are promising, we acknowledge the limitation of using cell culture models. Future investigations should prioritize in vivo validation using animal models to strengthen the clinical relevance of these findings.</p></sec><sec><title>Acknowledgments</title><p>We thank all the volunteers who participated in the study.</p></sec><sec><title>Author contributions</title><p><bold>Conceptualization:</bold> Xiaolian Yi, Shiqiang Shang.</p><p><bold>Validation:</bold> Xiaolian Yi.</p><p><bold>Visualization:</bold> Xiaolian Yi.</p><p><bold>Writing &#x02013; original draft:</bold> Xiaolian Yi.</p><p><bold>Writing &#x02013; review &#x00026; editing:</bold> Xiaolian Yi, Shiqiang Shang.</p><p><bold>Data curation:</bold> Lifang Liu.</p><p><bold>Formal analysis:</bold> Ran Tao.</p><p><bold>Investigation:</bold> Wei Li.</p><p><bold>Methodology:</bold> Huamei Li.</p><p><bold>Software:</bold> Huamei Li.</p><p><bold>Project administration:</bold> Lin He.</p><p><bold>Resources:</bold> Yujie Liu.</p></sec></body><back><fn-group><fn fn-type="abbr"><p>
<def-list><title>Abbreviations:</title><def-item><term>EGR-1</term><def><p>early growth response gene 1</p></def></def-item><def-item><term>FBS</term><def><p>fetal bovine serum</p></def></def-item><def-item><term>FK506</term><def><p>tacrolimus</p></def></def-item><def-item><term>HCMV</term><def><p>human cytomegalovirus</p></def></def-item><def-item><term>HEF</term><def><p>human embryo fibroblast</p></def></def-item><def-item><term>IFN-&#x003b3;</term><def><p>interferon-&#x003b3;</p></def></def-item><def-item><term>IL</term><def><p>interleukin</p></def></def-item><def-item><term>lncRNA4.9</term><def><p>long noncoding RNA</p></def></def-item><def-item><term>MOI</term><def><p>multiplicity of infection</p></def></def-item><def-item><term>PCR</term><def><p>polymerase chain reaction</p></def></def-item><def-item><term>PHA</term><def><p>phytohemagglutinin A</p></def></def-item><def-item><term>RT-PCR</term><def><p>reverse transcription polymerase chain reaction</p></def></def-item><def-item><term>TGF-&#x003b2;1</term><def><p>transforming growth factor-&#x003b2;1</p></def></def-item><def-item><term>THP-1</term><def><p>human acute monocytic leukemia cell line,</p></def></def-item><def-item><term>TNF-&#x003b1;</term><def><p>tumor necrosis factor-alpha</p></def></def-item></def-list>
</p></fn></fn-group><fn-group><fn fn-type="financial-disclosure"><p>This study was financially supported by the National Natural Science Foundation of China (Grant number: 81671495) and the Analysis and Testing Foundation of Zhejiang Province (Grant number: LGC19H200006).</p></fn><fn fn-type="other"><p>This study protocol was reviewed and approved by Children&#x02019;s Hospital affiliated to Zhejiang University School of Medicine, China, approval number (2021-IRB-296). The written informed consent was obtained from all of the donors.</p></fn><fn fn-type="COI-statement"><p>The authors have no conflicts of interest to disclose.</p></fn><fn fn-type="other"><p>The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.</p></fn><fn fn-type="other"><p>How to cite this article: Yi X, Liu L, Tao R, Li W, Li H, He L, Liu Y, Shang S. The effect of T cells on the lncRNA4.9-TGF-&#x003b2;1 axis in HCMV latently infected cells. Medicine 2025;104:20(e42400).</p></fn></fn-group><ref-list><title>References</title><ref id="R1"><label>[1]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohammad</surname><given-names>A-A</given-names></name><name><surname>Costa</surname><given-names>H</given-names></name><name><surname>Land&#x000e1;zuri</surname><given-names>N</given-names></name><etal/></person-group>. <article-title>Human cytomegalovirus microRNAs are carried by virions and dense bodies and are delivered to target cells.</article-title>
<source>J Gen Virol</source>. <year>2017</year>;<volume>98</volume>:<fpage>1058</fpage>&#x02013;<lpage>72</lpage>.<pub-id pub-id-type="pmid">28589873</pub-id>
</mixed-citation></ref><ref id="R2"><label>[2]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rossetto</surname><given-names>CC</given-names></name><name><surname>Tarrant-Elorza</surname><given-names>M</given-names></name><name><surname>Pari</surname><given-names>GS</given-names></name></person-group>. <article-title>Cis and trans acting factors involved in human cytomegalovirus experimental and natural latent infection of CD14 (+) monocytes and CD34 (+) cells.</article-title>
<source>PLoS Pathog</source>. <year>2013</year>;<volume>9</volume>:<fpage>e1003366</fpage>.<pub-id pub-id-type="pmid">23717203</pub-id>
</mixed-citation></ref><ref id="R3"><label>[3]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sinclair</surname><given-names>JH</given-names></name><name><surname>Reeves</surname><given-names>MB</given-names></name></person-group>. <article-title>Human cytomegalovirus manipulation of latently infected cells.</article-title>
<source>Viruses</source>. <year>2013</year>;<volume>5</volume>:<fpage>2803</fpage>&#x02013;<lpage>24</lpage>.<pub-id pub-id-type="pmid">24284875</pub-id>
</mixed-citation></ref><ref id="R4"><label>[4]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>SH</given-names></name><name><surname>Caviness</surname><given-names>K</given-names></name><name><surname>Albright</surname><given-names>ER</given-names></name><etal/></person-group>. <article-title>Long and short isoforms of the human cytomegalovirus UL138 protein silence IE1 transcription and promote latency.</article-title>
<source>J Virol</source>. <year>2016</year>;<volume>90</volume>:<fpage>9483</fpage>&#x02013;<lpage>94</lpage>.<pub-id pub-id-type="pmid">27512069</pub-id>
</mixed-citation></ref><ref id="R5"><label>[5]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Pan</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>The influence of HCMV infection on autophagy in THP-1 cells.</article-title>
<source>Medicine (Baltimore)</source>. <year>2017</year>;<volume>96</volume>:<fpage>e8298</fpage>.<pub-id pub-id-type="pmid">29095258</pub-id>
</mixed-citation></ref><ref id="R6"><label>[6]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mlera</surname><given-names>L</given-names></name><name><surname>Moy</surname><given-names>M</given-names></name><name><surname>Maness</surname><given-names>K</given-names></name><name><surname>Tran</surname><given-names>LN</given-names></name><name><surname>Goodrum</surname><given-names>FD</given-names></name></person-group>. <article-title>The role of the human cytomegalovirus UL133-UL138 gene locus in latency and reactivation.</article-title>
<source>Viruses</source>. <year>2020</year>;<volume>12</volume>:<fpage>714</fpage>.<pub-id pub-id-type="pmid">32630219</pub-id>
</mixed-citation></ref><ref id="R7"><label>[7]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Wu</surname><given-names>Z</given-names></name><name><surname>Fu</surname><given-names>X</given-names></name><name><surname>Han</surname><given-names>W</given-names></name></person-group>. <article-title>lncRNAs: insights into their function and mechanics in underlying disorders.</article-title>
<source>Mutat Res Rev Mutat Res</source>. <year>2014</year>;<volume>762</volume>:<fpage>1</fpage>&#x02013;<lpage>21</lpage>.<pub-id pub-id-type="pmid">25485593</pub-id>
</mixed-citation></ref><ref id="R8"><label>[8]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gatherer</surname><given-names>D</given-names></name><name><surname>Seirafian</surname><given-names>S</given-names></name><name><surname>Cunningham</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>High-resolution human cytomegalovirus transcriptome.</article-title>
<source>Proc Natl Acad Sci U S A</source>. <year>2011</year>;<volume>108</volume>:<fpage>19755</fpage>&#x02013;<lpage>60</lpage>.<pub-id pub-id-type="pmid">22109557</pub-id>
</mixed-citation></ref><ref id="R9"><label>[9]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tai-Schmiedel</surname><given-names>J</given-names></name><name><surname>Karniely</surname><given-names>S</given-names></name><name><surname>Lau</surname><given-names>B</given-names></name><etal/></person-group>. <article-title>Human cytomegalovirus long noncoding RNA4.9 regulates viral DNA replication.</article-title>
<source>PLoS Pathog</source>. <year>2020</year>;<volume>16</volume>:<fpage>e1008390</fpage>.<pub-id pub-id-type="pmid">32294138</pub-id>
</mixed-citation></ref><ref id="R10"><label>[10]</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>LF</given-names></name></person-group>. <article-title>Role of LncRNA 4.9 in Latent Infection With Cytomegalovirus and Its Mechanisms</article-title> [MA thesis]. <publisher-name>Zhejiang University</publisher-name>; <year>2019</year>.</mixed-citation></ref><ref id="R11"><label>[11]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmad</surname><given-names>SH</given-names></name><name><surname>Al Moussawi</surname><given-names>F</given-names></name><name><surname>El Baba</surname><given-names>R</given-names></name><etal/></person-group>. <article-title>Identification of UL69 gene and protein in cytomegalovirus-transformed human mammary epithelial cells.</article-title>
<source>Front Oncol</source>. <year>2021</year>;<volume>11</volume>:<fpage>627866</fpage>.<pub-id pub-id-type="pmid">33937031</pub-id>
</mixed-citation></ref><ref id="R12"><label>[12]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdulkadir</surname><given-names>SA</given-names></name><name><surname>Carbone</surname><given-names>JM</given-names></name><name><surname>Naughton</surname><given-names>CK</given-names></name><name><surname>Humphrey</surname><given-names>PA</given-names></name><name><surname>Catalona</surname><given-names>WJ</given-names></name><name><surname>Mibrandt</surname><given-names>J</given-names></name></person-group>. <article-title>Frequent and early loss of the EGR1 corepressor NAB2 in human prostate carcinoma.</article-title>
<source>Hum Pathol</source>. <year>2001</year>;<volume>32</volume>:<fpage>935</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">11567222</pub-id>
</mixed-citation></ref><ref id="R13"><label>[13]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoo</surname><given-names>YD</given-names></name><name><surname>Chiou</surname><given-names>CJ</given-names></name><name><surname>Choi</surname><given-names>KS</given-names></name><etal/></person-group>. <article-title>The IE2 regulatory protein of human cytomegalovirus induces expression of the human transforming growth factor beta1 gene through an Egr-1 binding site.</article-title>
<source>J Virol</source>. <year>1996</year>;<volume>70</volume>:<fpage>7062</fpage>&#x02013;<lpage>70</lpage>.<pub-id pub-id-type="pmid">8794351</pub-id>
</mixed-citation></ref><ref id="R14"><label>[14]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname><given-names>K-Y</given-names></name><name><surname>Shang</surname><given-names>S-Q</given-names></name><name><surname>Chen</surname><given-names>Y-H</given-names></name><name><surname>Wu</surname><given-names>W</given-names></name><name><surname>Qiao</surname><given-names>H-J</given-names></name><name><surname>Tao</surname><given-names>R</given-names></name></person-group>. <article-title>[Mannose-binding lectin (MBL) inhibits human cytomegalovirus infection of human MD-DC].</article-title>
<source>Sichuan Da Xue Xue Bao Yi Xue Ban</source>. <year>2011</year>;<volume>42</volume>:<fpage>599</fpage>&#x02013;<lpage>603, 615</lpage>.<pub-id pub-id-type="pmid">22007480</pub-id>
</mixed-citation></ref><ref id="R15"><label>[15]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hafezi</surname><given-names>M</given-names></name><name><surname>Lin</surname><given-names>M</given-names></name><name><surname>Chia</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Immunosuppressive drug-resistant armored T-cell receptor T cells for immune therapy of HCC in liver transplant patients.</article-title>
<source>Hepatology</source>. <year>2021</year>;<volume>74</volume>:<fpage>200</fpage>&#x02013;<lpage>13</lpage>.<pub-id pub-id-type="pmid">33249625</pub-id>
</mixed-citation></ref><ref id="R16"><label>[16]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inge</surname><given-names>TH</given-names></name><name><surname>Hoover</surname><given-names>SK</given-names></name><name><surname>Susskind</surname><given-names>BM</given-names></name><name><surname>Barrett</surname><given-names>SK</given-names></name><name><surname>Bear</surname><given-names>HD</given-names></name></person-group>. <article-title>Inhibition of tumor-specific cytotoxic T-lymphocyte responses by transforming growth factor beta 1.</article-title>
<source>Cancer Res</source>. <year>1992</year>;<volume>52</volume>:<fpage>1386</fpage>&#x02013;<lpage>92</lpage>.<pub-id pub-id-type="pmid">1531782</pub-id>
</mixed-citation></ref><ref id="R17"><label>[17]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poole</surname><given-names>E</given-names></name><name><surname>McGregor Dallas</surname><given-names>SR</given-names></name><name><surname>Colston</surname><given-names>J</given-names></name><name><surname>Joseph</surname><given-names>RSV</given-names></name><name><surname>Sinclair</surname><given-names>J</given-names></name></person-group>. <article-title>Virally induced changes in cellular microRNAs maintain latency of human cytomegalovirus in CD34&#x0207a; progenitors.</article-title>
<source>J Gen Virol</source>. <year>2011</year>;<volume>92</volume>(<issue>Pt 7</issue>):<fpage>1539</fpage>&#x02013;<lpage>49</lpage>.<pub-id pub-id-type="pmid">21471310</pub-id>
</mixed-citation></ref><ref id="R18"><label>[18]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reeves</surname><given-names>MB</given-names></name><name><surname>Lehner</surname><given-names>PJ</given-names></name><name><surname>Sissons</surname><given-names>JGP</given-names></name><name><surname>Sinclair</surname><given-names>JH</given-names></name></person-group>. <article-title>An in vitro model for the regulation of human cytomegalovirus latency and reactivation in dendritic cells by chromatin remodelling.</article-title>
<source>J Gen Virol</source>. <year>2005</year>;<volume>86</volume>(<issue>Pt 11</issue>):<fpage>2949</fpage>&#x02013;<lpage>54</lpage>.<pub-id pub-id-type="pmid">16227215</pub-id>
</mixed-citation></ref><ref id="R19"><label>[19]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jackson</surname><given-names>SE</given-names></name><name><surname>Mason</surname><given-names>GM</given-names></name><name><surname>Wills</surname><given-names>MR</given-names></name></person-group>. <article-title>Human cytomegalovirus immunity and immune evasion.</article-title>
<source>Virus Res</source>. <year>2011</year>;<volume>157</volume>:<fpage>151</fpage>&#x02013;<lpage>60</lpage>.<pub-id pub-id-type="pmid">21056604</pub-id>
</mixed-citation></ref><ref id="R20"><label>[20]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stern</surname><given-names>JL</given-names></name><name><surname>Slobedman</surname><given-names>B</given-names></name></person-group>. <article-title>Human cytomegalovirus latent infection of myeloid cells directs monocyte migration by up-regulating monocyte chemotactic protein-1.</article-title>
<source>J Immunol</source>. <year>2008</year>;<volume>180</volume>:<fpage>6577</fpage>&#x02013;<lpage>85</lpage>.<pub-id pub-id-type="pmid">18453576</pub-id>
</mixed-citation></ref><ref id="R21"><label>[21]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheung</surname><given-names>AKL</given-names></name><name><surname>Gottlieb</surname><given-names>DJ</given-names></name><name><surname>Plachter</surname><given-names>B</given-names></name><etal/></person-group>. <article-title>The role of the human cytomegalovirus UL111A gene in down-regulating CD4+ T-cell recognition of latently infected cells: implications for virus elimination during latency.</article-title>
<source>Blood</source>. <year>2009</year>;<volume>114</volume>:<fpage>4128</fpage>&#x02013;<lpage>37</lpage>.<pub-id pub-id-type="pmid">19706889</pub-id>
</mixed-citation></ref><ref id="R22"><label>[22]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Opal</surname><given-names>SM</given-names></name><name><surname>DePalo</surname><given-names>VA</given-names></name></person-group>. <article-title>Anti-inflammatory cytokines.</article-title>
<source>Chest</source>. <year>2000</year>;<volume>117</volume>:<fpage>1162</fpage>&#x02013;<lpage>72</lpage>.<pub-id pub-id-type="pmid">10767254</pub-id>
</mixed-citation></ref><ref id="R23"><label>[23]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Businger</surname><given-names>R</given-names></name><name><surname>Kivim&#x000e4;ki</surname><given-names>S</given-names></name><name><surname>Simeonov</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Comprehensive analysis of human cytomegalovirus- and HIV-mediated plasma membrane remodeling in macrophages.</article-title>
<source>mBio</source>. <year>2021</year>;<volume>12</volume>:<fpage>e0177021</fpage>.<pub-id pub-id-type="pmid">34399625</pub-id>
</mixed-citation></ref><ref id="R24"><label>[24]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crough</surname><given-names>T</given-names></name><name><surname>Khanna</surname><given-names>R</given-names></name></person-group>. <article-title>Immunobiology of human cytomegalovirus: from bench to bedside.</article-title>
<source>Clin Microbiol Rev</source>. <year>2009</year>;<volume>22</volume>:<fpage>76</fpage>&#x02013;<lpage>98, Table of Contents</lpage>.<pub-id pub-id-type="pmid">19136435</pub-id>
</mixed-citation></ref><ref id="R25"><label>[25]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goodrum</surname><given-names>F</given-names></name></person-group>. <article-title>Human cytomegalovirus latency: approaching the Gordian knot.</article-title>
<source>Annu Rev Virol</source>. <year>2016</year>;<volume>3</volume>:<fpage>333</fpage>&#x02013;<lpage>57</lpage>.<pub-id pub-id-type="pmid">27501258</pub-id>
</mixed-citation></ref></ref-list></back></article>